# FDA recall D-1046-2017

> **Hospira a Pfizer Company** · Class II · drug recall initiated 2017-06-15.

## Product

Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4.4 mEq/mL) 15 mL, Single-dose, Caution: Must Be Diluted, Rx Only, Mfd by Hospira, Inc. Lake Forest, IL 60045 USA, NDC: 0409-7295-01

## Reason for recall

Lack of Sterility Assurance

## Distribution

U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore

## Key facts

- **Recall number:** D-1046-2017
- **Recalling firm:** Hospira a Pfizer Company
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-06-15
- **Report date:** 2017-08-09
- **Termination date:** 2020-07-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Rocky Mount, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1046-2017

## Citation

> AI Analytics. FDA recall D-1046-2017. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1046-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*